We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPRO
351
DELISTED
Open Lending Corp
LPRO
| $27.7M | 0.06% |
782,595
-1,210,234
| -61% | -$45.6M |
|
352
AutoZone
AZO
$50.1B
| $27.7M | 0.06% |
+19,715
| New | +$24.4M |
|
|
SUM
353
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $27.7M | 0.06% |
1,003,742
-262,756
| -21% | -$6.6M |
|
|
AMK
354
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $27.3M | 0.06% |
1,169,304
+254,318
| +28% | +$6.15M |
|
355
Clorox
CLX
$12.8B
| $27.2M | 0.06% |
140,853
+1,600
| +1% | +$308K |
|
|
ITCI
356
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $27.1M | 0.06% |
800,000
+37,583
| +5% | +$1.3M |
|
357
CDW
CDW
$17.7B
| $27.1M | 0.06% |
163,500
+2,100
| +1% | +$314K |
|
358
Advance Auto Parts
AAP
$3.49B
| $27.1M | 0.06% |
147,600
-458,292
| -76% | -$76.9M |
|
|
MXIM
359
DELISTED
Maxim Integrated Products
MXIM
| $27M | 0.06% |
296,000
+1,700
| +0.6% | +$156K |
|
360
Hayward Holdings
HAYW
$3.32B
| $27M | 0.06% |
+1,600,000
| New | +$26.7M |
|
361
Viavi Solutions
VIAV
$10B
| $26.9M | 0.05% |
1,713,721
-445,500
| -21% | -$7.19M |
|
362
NiSource
NI
$20.8B
| $26.8M | 0.05% |
1,110,562
+691,800
| +165% | +$15.6M |
|
|
HCIC
363
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
| $26.5M | 0.05% |
+2,700,000
| New | +$26.9M |
|
364
Goodyear
GT
$1.94B
| $26.4M | 0.05% |
+1,500,000
| New | +$21.7M |
|
365
Keysight
KEYS
$57.6B
| $26.3M | 0.05% |
183,412
+22,287
| +14% | +$3.16M |
|
366
Realty Income
O
$59B
| $26.1M | 0.05% |
423,946
+29,619
| +8% | +$1.75M |
|
367
Southern Company
SO
$107B
| $26.1M | 0.05% |
419,600
-757,100
| -64% | -$45.3M |
|
368
Expedia Group
EXPE
$36.8B
| $26M | 0.05% |
151,100
+1,900
| +1% | +$292K |
|
369
Hershey
HSY
$36.8B
| $25.7M | 0.05% |
162,485
+1,700
| +1% | +$256K |
|
|
MDVL
370
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $25.6M | 0.05% |
36,562
-7,352
| -17% | -$5.29M |
|
371
Nucor
NUE
$61.9B
| $25.5M | 0.05% |
317,335
-6,200
| -2% | -$376K |
|
372
Valero Energy
VLO
$87.2B
| $25.2M | 0.05% |
352,600
+303,302
| +615% | +$20.6M |
|
373
AngioDynamics
ANGO
$625M
| $25.2M | 0.05% |
+1,075,000
| New | +$21.7M |
|
374
Copart
CPRT
$26.9B
| $25.1M | 0.05% |
924,400
+18,400
| +2% | +$519K |
|
|
JNCE
375
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $24.9M | 0.05% |
2,428,023
+956,023
| +65% | +$10.5M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.